Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants
Clinical trial NCT02302066 · COMPLETED
Trial details
- NCT number
- NCT02302066
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-05
- Primary completion
- 2019-02-18
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.